REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea · Delayed Price · Currency is KRW 9,960.00
-80.00 (-0.80%)
Apr 2, 2026, 3:30 PM KST
REYON Pharmaceutical Market Cap
REYON Pharmaceutical has a market cap or net worth of 182.68 billion as of April 2, 2026. Its market cap has decreased by -17.55% in one year.
Market Cap
182.68B
Enterprise Value
388.38B
Revenue
149.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,960.00
Market Cap Chart
Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 182.68B, an increase of 11.01%. That is a compound annual growth rate of 0.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 184.14B | -6.86% |
| Dec 30, 2025 | 197.72B | -16.04% |
| Dec 30, 2024 | 235.50B | -22.37% |
| Dec 28, 2023 | 303.36B | -21.07% |
| Dec 29, 2022 | 384.35B | -39.10% |
| Dec 30, 2021 | 631.11B | 61.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samil Pharmaceutical Co.,Ltd | 208.05B |
| Suheung | 208.02B |
| JW Lifescience | 204.86B |
| AptaBio Therapeutics | 204.24B |
| Kyongbo Pharmaceutical | 200.82B |
| Jeil Pharmaceutical Co.,Ltd | 199.34B |
| Whan In Pharm | 192.60B |
| SAMSUNG PHARM. Co., LTD. | 178.36B |